MDT Medtronic plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$78.7

Market cap

$100.91B

P/E Ratio

28.41

Dividend/share

$2.77

EPS

$2.77

Enterprise value

$124.65B

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around ...

Highlights
Medtronic's revenue has increased by 3.6% YoY
MDT's gross profit is up by 3.1% year-on-year
The price to earnings (P/E) is 12% lower than the 5-year quarterly average of 32.3 but 2.2% higher than the last 4 quarters average of 27.8
Medtronic's quick ratio has decreased by 15% YoY and by 10% from the previous quarter
The EPS has declined by 12% since the previous quarter and by 2.1% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com
Peers: BSX SYK EW JNJ

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.28B
Market cap
$100.91B
Enterprise value
$124.65B
Valuations
Price to earnings (P/E)
28.41
Price to book (P/B)
2.08
Price to sales (P/S)
3.23
EV/EBIT
22.55
EV/EBITDA
15.25
EV/Sales
3.85
Earnings
Revenue
$32.36B
EBIT
$5.53B
EBITDA
$8.18B
Free cash flow
$5.2B
Per share
EPS
$2.77
Free cash flow per share
$3.92
Book value per share
$37.82
Revenue per share
$24.38
TBVPS
$26.94
Balance sheet
Total assets
$89.98B
Total liabilities
$39.56B
Debt
$25.02B
Equity
$50.21B
Working capital
$11.15B
Liquidity
Debt to equity
0.5
Current ratio
2.03
Quick ratio
1.31
Net debt/EBITDA
2.9
Margins
EBITDA margin
25.3%
Gross margin
65.3%
Net margin
11.4%
Operating margin
15.9%
Efficiency
Return on assets
4.1%
Return on equity
7.2%
Return on invested capital
11.2%
Return on capital employed
7%
Return on sales
17.1%
Dividend
Dividend yield
3.52%
DPS
$2.77
Payout ratio
100%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
0.31%
1 week
-0.98%
1 month
-1.69%
1 year
-12.94%
YTD
-4.47%
QTD
-0.01%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$32.36B
Gross profit
$21.15B
Operating income
$5.15B
Net income
$3.68B
Gross margin
65.3%
Net margin
11.4%
MDT's net margin is down by 12% since the previous quarter and by 5% year-on-year
The net income has contracted by 12% from the previous quarter and by 2.2% YoY
The operating margin has declined by 10% year-on-year and by 9% since the previous quarter
The operating income has decreased by 9% QoQ and by 6% YoY

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
MDT P/E details
P/E
28.41
P/B
2.08
P/S
3.23
EV/EBIT
22.55
EV/EBITDA
15.25
EV/Sales
3.85
The EPS has declined by 12% since the previous quarter and by 2.1% year-on-year
The price to earnings (P/E) is 12% lower than the 5-year quarterly average of 32.3 but 2.2% higher than the last 4 quarters average of 27.8
The stock's price to book (P/B) is 20% less than its 5-year quarterly average of 2.6
The company's equity fell by 3% QoQ and by 2.5% YoY
MDT's P/S is 27% lower than its 5-year quarterly average of 4.4 and 5% lower than its last 4 quarters average of 3.4
Medtronic's revenue has increased by 3.6% YoY

Efficiency

How efficient is Medtronic business performance
The company's return on invested capital fell by 16% YoY and by 11% QoQ
Medtronic's return on equity has decreased by 12% QoQ
MDT's return on assets is down by 11% since the previous quarter
The return on sales has declined by 11% since the previous quarter and by 10% year-on-year

Dividends

What is MDT's dividend history
Dividend details
DPS
$2.77
Dividend yield
3.52%
Payout ratio
100%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 127% greater than the total liabilities
Medtronic's quick ratio has decreased by 15% YoY and by 10% from the previous quarter
The company's current ratio fell by 15% YoY and by 12% QoQ
MDT's debt is 50% smaller than its equity
Medtronic's debt to equity has increased by 6% YoY and by 2% from the previous quarter
The company's equity fell by 3% QoQ and by 2.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.